130 (PB-130) Poster - Effective anti-diarrhea strategies for pyrotinib (PYR) plus trastuzumab (H) and docetaxel (T) in patients (pts) with HER2+ metastatic breast cancer (mBC): a multicenter, phase 1 trial (PHAENNA).

Authors :: Yao, H.
Shi, Y.
Yao, Y.
Li, H.
Zhou, H.
Wang, S.
Qin, Q.
Li, W.
Geng, C.
Wang, M.
Wang, X.
Cao, Y.
Yu, Z.
Du, C.
Zhao, W.
Wu, S.
Cui, Y.
Liu, P.
Lin, J.
Song, E.
Source :: European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.
Publication Year :: 2024

Subjects :: *THERAPEUTIC use of antineoplastic agents
*DOCETAXEL
*DIARRHEA
*TRASTUZUMAB
*ANTIDIARRHEALS
*BREAST tumors
*ANTINEOPLASTIC agents
*TREATMENT effectiveness
*CONFERENCES & conventions
*CANCER patients
*METASTASIS

Full Text Access

Tools